Sharing injection equipment

Essential answer

Sharing injection equipment is part of the Center’s transmission record.

HIV transmission requires a biologically relevant route, sufficient virus and access to susceptible cells. The presence of one factor alone does not establish that transmission occurred.

Complete public explanation

Evidence-based explanations of transmission routes and the factors that influence risk.

Use the information with its source date, population and jurisdiction. A general explanation cannot determine an individual’s diagnosis, eligibility, regimen or legal obligations.

Key considerations

Route, body fluid, tissue exposure, viral load and prevention all affect context.
Effective treatment with sustained viral suppression prevents sexual transmission.
PrEP, PEP, sterile equipment, condoms and blood-safety systems address different routes.
An individual concern is assessed through qualified services, not an online risk score.

Research and evidence questions

01How can prevention coverage be matched to locally important routes?

02Which service models reduce delay after a possible exposure?

03How do stigma and criminalization affect testing and disclosure?

04Which messages reduce fear without minimizing real risk?

Professional and academic evidence

Professional interpretation of sharing injection equipment adds study design, population, comparator, outcomes, statistical methods, limitations, conflicts, guideline adoption, geographic applicability, replication and integrity status.

Evidence record fields for Sharing injection equipment
Field	What the Center displays
Meaning and scope	Definition, mechanism, intended use and what should not be inferred.
Population and jurisdiction	Age, sex and gender, geography, HIV subtype, clinical context and issuing authority.
Outcome	Clinical, virologic, diagnostic, public-health or implementation outcome and follow-up.
Provenance	Original source, identifier, version, funding, conflicts, access date and review.
Integrity	Protocol changes, corrections, expressions of concern, retractions and later evidence.

Principal sources and evidence gateways

Links checked 18 August 2026

01

NIH HIV/AIDS treatment, prevention and research portalNIH HIVinfo · Research strategy · Access checked 18 Aug 2026

02

Clinical guidelines for HIV prevention and treatmentNIH Clinicalinfo · Guideline · Access checked 18 Aug 2026

03

NIH Strategic Plan for HIV and HIV-Related Research, updated 2025NIH Office of AIDS Research · Research strategy · Access checked 18 Aug 2026

Additional permanent evidence gateways

WHO HIV topic and guidelines NIH HIVinfo public information NIH Clinicalinfo guidelines UNAIDS global data ClinicalTrials.gov WHO ICTRP PubMed